Skip to main content
. 2020 Apr 3;17(7):2450. doi: 10.3390/ijerph17072450

Table 4.

Adjusted Hazard Rations of Mortality among Patients with Schizophrenic Disorders Based on the Charlson Comorbidities.

Charlson Comorbidities Univariate Analysis Multivariate Analysis #
HR 95%CI aHR 95%CI
Myocardial infarction 6.83 4.80–9.72 *** 2.36 1.66–3.36 ***
Congestive heart failure 7.04 5.86–8.45 *** 2.74 2.27–3.29 ***
Peripheral vascular disease 3.52 2.50–4.95 *** 2.05 1.46–2.89 ***
Cerebrovascular disease 3.53 3.18–3.91 *** 1.85 1.67–2.06 ***
Dementia 4.39 3.90–4.95 *** 1.78 1.58–2.01 ***
Chronic pulmonary disease 2.16 1.99–2.35 *** 1.49 1.37–1.62 ***
Rheumatic disease 1.47 1.28–1.69 *** 1.21 1.05–1.39 ***
Peptic ulcer disease 1.68 1.55–1.82 *** 1.36 1.25–1.47 ***
Mild liver disease 2.05 1.86–2.27 *** 1.81 1.64–2.00 ***
Diabetes mellitus without end-organ damage 3.14 2.91–3.39 *** 1.86 1.73–2.01 ***
Diabetes mellitus with end-organ damage 4.66 3.88–5.60 *** 2.53 2.10–3.04 ***
Hemiplegia 3.33 2.40–4.62 *** 2.17 1.56–3.01 ***
Renal disease 3.75 3.20–4.39 *** 2.53 2.15–2.96 ***
Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin 3.97 3.34–4.73 *** 3.13 2.63–3.72 ***
Moderate liver disease 7.82 5.98–10.21 *** 5.59 4.27–7.31 ***
Metastatic solid tumor 10.08 6.69–15.17 *** 6.31 4.19–9.50 ***
HIV/AIDS - - - -

*** p < 0.001; CI = confidence interval, HR = hazard ratio, aHR = adjusted hazard ratio, AIDS = acquired immunodeficiency syndrome, HIV = human immunodeficiency virus. # Adjusted for the patient’s age, gender, socioeconomic status, geographic regions, and teaching level of hospital.